Caplight Logo









Megarobo

Megarobo

Private
Beijing, BeijingHealthcare & Life Scienceswww.megarobo.tech

Last Round

Series C

Jun 15, 2022

Est. Valuation

$1B

Total Funding Raised

$426.51M

Company Overview

Megarobo is a robotics and automation company that specializes in creating collaborative robots designed to enhance the efficiency of life science research through innovative laboratory automation solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Industrial Robotics, Drug Discovery, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

lab automationlife sciences automationcollaborative robotscobotsautonomous agentsAI-powered automationsmart manufacturingmulti-agent systemsindustrial roboticsdrug discovery automationmachine visionCloud Labin-vitro diagnosticsIVDcell and gene therapyrobot-as-a-serviceRaaSprecision agriculture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Megarobo Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Megarobo Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CJun 15, 2022
Series BMay 28, 2021
Series A ExtensionJun 25, 2019
AngelOct 19, 2017
View all Funding Rounds

Megarobo Investors

Notable investors and investment history

InvestorRounds
Redview CapitalSeries C
Gobi PartnersSeries A Extension
Joy CapitalSeries A Extension, Series B
Starr Capital LLCSeries C
Zhulu CapitalAngel
Liando InvestmentSeries B
Power Cloud Venture CapitalAngel
View all Investors

Megarobo Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Megarobo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Megarobo's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing, Beijing
Year Founded2016
Last FundingJun 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.